76
|
Platzbecker U, Germing U, Giagounidis A, Götze K, Kiewe P, Mayer K, Ottmann O, Radsak M, Wolff T, Haase D, Hankin M, Wilson D, Zhang X, Laadem A, Sherman M, Attie K. 53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY. Leuk Res 2015. [DOI: 10.1016/s0145-2126(15)30054-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
77
|
Kratz CP, Franke L, Peters H, Kohlschmidt N, Kazmierczak B, Finckh U, Bier A, Eichhorn B, Blank C, Kraus C, Kohlhase J, Pauli S, Wildhardt G, Kutsche K, Auber B, Christmann A, Bachmann N, Mitter D, Cremer FW, Mayer K, Daumer-Haas C, Nevinny-Stickel-Hinzpeter C, Oeffner F, Schlüter G, Gencik M, Überlacker B, Lissewski C, Schanze I, Greene MH, Spix C, Zenker M. Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes. Br J Cancer 2015; 112:1392-7. [PMID: 25742478 PMCID: PMC4402457 DOI: 10.1038/bjc.2015.75] [Citation(s) in RCA: 140] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Revised: 01/15/2015] [Accepted: 01/27/2015] [Indexed: 12/29/2022] Open
Abstract
Background: Somatic mutations affecting components of the Ras-MAPK pathway are a common feature of cancer, whereas germline Ras pathway mutations cause developmental disorders including Noonan, Costello, and cardio-facio-cutaneous syndromes. These ‘RASopathies' also represent cancer-prone syndromes, but the quantitative cancer risks remain unknown. Methods: We investigated the occurrence of childhood cancer including benign and malignant tumours of the central nervous system in a group of 735 individuals with germline mutations in Ras signalling pathway genes by matching their information with the German Childhood Cancer Registry. Results: We observed 12 cases of cancer in the entire RASopathy cohort vs 1.12 expected (based on German population-based incidence rates). This corresponds to a 10.5-fold increased risk of all childhood cancers combined (standardised incidence ratio (SIR)=10.5, 95% confidence interval=5.4–18.3). The specific cancers included juvenile myelomonocytic leukaemia=4; brain tumour=3; acute lymphoblastic leukaemia=2; rhabdomyosarcoma=2; and neuroblastoma=1. The childhood cancer SIR in Noonan syndrome patients was 8.1, whereas that for Costello syndrome patients was 42.4. Conclusions: These data comprise the first quantitative evidence documenting that the germline mutations in Ras signalling pathway genes are associated with increased risks of both childhood leukaemia and solid tumours.
Collapse
|
78
|
Witt C, Mayer K, Wilke A, Grohé C. Mutation c.5191_5194dupAACC im TSC2-Gen bei tuberöser Sklerose mit pulmonaler Lymphangioleiomyomatose. Pneumologie 2015. [DOI: 10.1055/s-0035-1544812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
79
|
Mayer K, Hahn-Ast C, Mückter S, Schmitz A, Krause S, Felder L, Bekeredjian-Ding I, Molitor E, Brossart P, von Lilienfeld-Toal M. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia. Support Care Cancer 2015; 23:1321-9. [PMID: 25617073 DOI: 10.1007/s00520-015-2621-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Accepted: 01/13/2015] [Indexed: 10/24/2022]
Abstract
PURPOSE Recent meta-analyses showed that antibiotic prophylaxis in patients with neutropenia after chemotherapy reduced the incidence of fever and mortality rate. Fluoroquinolones appear to be most effective and well tolerated. Thus, in April 2008, we changed our antibiotic prophylaxis regimen from cotrimoxazole/colistin (COT/COL) to the fluoroquinolone ciprofloxacin (CIP) in patients with acute myeloid leukemia (AML). The aim of this retrospective study was to compare efficacy and development of bacterial resistance with two different prophylaxis regimens over a time period of more than 4 years. METHODS Induction chemotherapy courses given for AML during the antibiotic prophylaxis period with COT/COL (01/2006-04/2008) and CIP (04/2008-06/2010) were retrospectively analyzed with a standard questionnaire. RESULTS Eighty-five courses in the COT/COL group and 105 in the CIP group were analyzed. The incidence of fever was not significantly different (COT/COL 80 % vs CIP 77 %; p = 0.724). Also, the rate of microbiologically documented infections was nearly the same (29 vs 26 %; p = 0.625). In addition, there was no significant difference in the incidence of clinically documented infections (11 vs 19 %; p = 0.155) or in the rates of detected gram-positive and gram-negative bacteria. Of note, there was no increase in resistance rates or cases with Clostridium difficile-associated diarrhea in the CIP group. CONCLUSION The antibiotic prophylaxis with CIP compared to COT/COL in AML was similarly effective with no increase in bacterial resistance. COT/COL may have the advantages of providing additional prophylaxis against Pneumocystis jirovecii pneumonia and leaving fluoroquinolones as an additional option for treatment of febrile neutropenia.
Collapse
|
80
|
Slavov C, Bellakbil N, Wahl J, Mayer K, Rück-Braun K, Burghardt I, Wachtveitl J, Braun M. Ultrafast coherent oscillations reveal a reactive mode in the ring-opening reaction of fulgides. Phys Chem Chem Phys 2015; 17:14045-53. [DOI: 10.1039/c5cp01878a] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Ultrafast coherent dynamics reveals a low frequency vibrational mode governing the photochromic ring-opening reaction in indolylfulgide molecular switches.
Collapse
|
81
|
Müller-Redetzky HC, Wienhold SM, Berg J, Hocke AC, Hippenstiel S, Hellwig K, Gutbier B, Opitz B, Neudecker J, Rückert J, Gruber AD, Kershaw O, Mayer K, Suttorp N, Witzenrath M. Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia. J Antimicrob Chemother 2014; 70:830-40. [DOI: 10.1093/jac/dku446] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
82
|
Hecker M, Mayer K, Askevold I, Collet P, Weigand MA, Krombach GA, Padberg W, Hecker A. [Acute pancreatitis]. Anaesthesist 2014; 63:253-63. [PMID: 24577182 PMCID: PMC7095909 DOI: 10.1007/s00101-014-2307-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Bei der akuten Pankreatitis handelt es sich um eine potenziell tödlich verlaufende Erkrankung mit individuell unterschiedlich ausgeprägter systemischer Beteiligung. Aus diesem Grund kommen der frühzeitigen Diagnose und nachfolgenden Risikostratifikation im klinischen Management dieser häufigen gastroenterologischen Erkrankung entscheidende Rollen zu. Schwere Verlaufsformen treten in etwa 20 % der Fälle auf und bedürfen zumeist intensivmedizinischer Überwachung und interdisziplinärer Behandlung. Therapeutisch stehen in der Akutphase die adäquate Flüssigkeitssubstitution und suffiziente Schmerztherapie im Vordergrund. Im Hinblick auf den Einsatz von Antibiotika und die Anpassung der Ernährung hat sich in den letzten Jahren ein Paradigmenwechsel vollzogen. Je nach Schwere der Erkrankung und möglichen Komplikationen können auch endoskopisch-/radiologisch-interventionelle Maßnahmen oder eine operative Versorgung notwendig werden.
Collapse
|
83
|
Harawa N, Wilton L, Wang L, Mao C, Kuo I, Penniman T, Shoptaw S, Griffith S, Williams JK, Cummings V, Mayer K, Koblin B. Types of female partners reported by black men who have sex with men and women (MSMW) and associations with intercourse frequency, unprotected sex and HIV and STI prevalence. AIDS Behav 2014; 18:1548-59. [PMID: 24523006 DOI: 10.1007/s10461-014-0704-4] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We used baseline data from a study of Black MSM/MSMW in 6 US cities to examine the association of female partnership types with disease prevalence and sexual behaviors among the 555 MSMW participants. MSMW reported more than three times as many total and unprotected sex acts with each primary as they did with each non-primary female partner. We compared MSMW whose recent female partners were: (1) all primary ("PF only", n = 156), (2) both primary and non-primary ("PF & NPF", n = 186), and (3) all non-primary ("NPF only", n = 213). HIV/STI prevalence did not differ significantly across groups but sexual behaviors did. The PF only group had the fewest male partners and was the most likely to have only primary male partners; the PF & NPF group was the most likely to have transgender partners. PF & NPF men reported the most sex acts (total and unprotected) with females; NPF only men reported the fewest. Implications for HIV risk and prevention are discussed.
Collapse
|
84
|
Schlitter MC, Rühl H, Thiesler T, Penner AH, Berens C, Wolf D, Mayer K. Erratum to: Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma. Ann Hematol 2014. [DOI: 10.1007/s00277-014-2097-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
85
|
Rosengarten B, Schweighoefer H, Mayer K. P48: Brain function in iNOS knock out or iNOS inhibited (l-NIL) mice under septic shock. Clin Neurophysiol 2014. [DOI: 10.1016/s1388-2457(14)50209-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
86
|
Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Tolg R, Anette Fiedler K, Abdel-Wahab M, Kufner S, Schneider S, Schunkert H, Ibrahim T, Mehilli J, Kastrati A, Kastrati A, Mehilli J, Richardt G, Mehran R, Gershlick A, Mehilli J, Burgdorf C, Byrne RA, Cassese S, Fusaro M, Hausleiter J, Hengstenberg C, Joner M, Kasel M, Kastrati A, Massberg S, Ott I, Pache J, Schunkert H, Seyfarth M, Sibbing D, Tiroch K, Laugwitz KL, Ibrahim T, Hoppmann P, Schneider S, Bradaric C, Richardt G, Abdel-Wahab M, Geist V, Schwarz B, Sulimov D, Tolg R, Schulz S, Schomig G, von Merzljak B, Luckmann J, Ruf J, Morath T, Holle H, Paul H, Vogel J, Hoesl K, Rifatov N, Pastor I, Maimer-Rodrigues F, Schulz M, Neudecker J, Mayer K, Hofmann F, Mann J, Hauschke D, Schmitt C, Poci D, Barthel P, Ndrepepa G, Keta D, Byrne RA, Kufner S, Piniek S, Hurt S, Kastrati S, Anette Fiedler K. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J 2014; 35:2285-94. [DOI: 10.1093/eurheartj/ehu182] [Citation(s) in RCA: 84] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
87
|
Schlitter MC, Rühl H, Thiesler T, Penner AH, Berens C, Wolf D, Mayer K. Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma. Ann Hematol 2014; 93:1795-6. [PMID: 24789322 DOI: 10.1007/s00277-014-2060-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2014] [Accepted: 03/15/2014] [Indexed: 11/29/2022]
|
88
|
Mayer K, Schulz S, Bernlochner I, Morath T, Braun S, Hausleiter J, Massberg S, Schunkert H, Laugwitz KL, Kastrati A, Sibbing D. A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Thromb Haemost 2014; 112:342-51. [PMID: 24718389 DOI: 10.1160/th13-10-0874] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2013] [Accepted: 03/04/2014] [Indexed: 11/05/2022]
Abstract
In clopidogrel-treated patients undergoing percutaneous coronary intervention (PCI), high platelet reactivity (HPR) is associated with a higher risk for thrombotic events including stent thrombosis (ST). A personalised therapy with selective intensification of treatment may improve HPR patients´ outcome in this setting although recent randomised trials are against this hypothesis. The aim of the ISAR-HPR registry was to assess whether clopidogrel-treated HPR patients benefit from selective intensification of P2Y12 receptor inhibition. For the registry, outcomes were compared between two cohorts. We identified 428 clopidogrel treated HPR patients (AU x min ≥468 on the Multiplate analyser) between 2007-2008 (historical control cohort) without a change of treatment based on platelet function (PF) testing results. Between 2009-2011, we identified 571 HPR patients (guided therapy cohort) and used this information for guidance and selective intensification of P2Y12 receptor directed treatment (reloading with clopidogrel, switch to prasugrel, re-testing) in a setting of routine PF testing. The primary outcome was the composite of death from any cause or ST after 30 days. Major bleeding according to TIMI criteria was also monitored. The incidence of the primary outcome was significantly lower in the guided vs the control cohort (7 [1.2%] vs 16 [3.7%] events; HR 0.32, 95% CI 0.13-0.79; p=0.009). The incidence of major bleeding was numerically but not statistically higher in the guided vs the control cohort (1.9 vs 0.7%; p=0.10). In conclusion, present findings are in support for a PF testing guided antiplatelet therapy with selective intensification of P2Y12 receptor inhibition. The issue of personalised antiplatelet treatment warrants further investigation in randomized and well-controlled clinical trials.
Collapse
|
89
|
Rosengarten B, Mayer K, Lichtenstern C. Aktuelle Therapie der Sepsis auf der neurologischen Intensivstation Teil 1: generelle Aspekte der Sepsistherapie. AKTUELLE NEUROLOGIE 2014. [DOI: 10.1055/s-0034-1370995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
90
|
Lukács A, Mayer K, Török A, Kiss-Tóth E, Barkai L. Better cardiorespiratory fitness associated with favourable metabolic control and health-related quality of life in youths with type 1 diabetes mellitus. ACTA ACUST UNITED AC 2014; 100:77-83. [PMID: 23471043 DOI: 10.1556/aphysiol.100.2013.1.7] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
OBJECTIVE to explore the relationship among health-related quality of life (HRQoL), clinical variables, anthropometric measures, physical activity and cardiorespiratory fitness in children and adolescents with type 1 diabetes.Furthermore, we aimed to find predictors of HRQoL and metabolic control. METHODS A total of 106 patients (sex ratio: 1:1) with mean HbA1c of 8.55 (± 1.44) % and diabetes duration of 5.15 (± 3.24) years were assessed. The average age was 13.22 (± 3.08) years. RESULTS We observed statistically significant negative medium correlation between HbA1c and VO2max (r = – 0.343; p = 0.000). There was statistically significant small positive correlation between the HRQoL and the maximal oxygen consumption (r = 0.208; p = 0.032). We found no significant correlation between the HbA1c and the patients' HRQoL. In the multiple linear regression analysis both the better metabolic control and the HRQoL was predicted by the VO2max, other variables had no effect. Physical activity level did not explain the HRQoL. Boys had significantly better HRQoL and less skinfold thickness than girls. CONCLUSION Better cardiorespiratory fitness associated with both favourable metabolic control and better HRQoL of diabetic youths.Regular aerobic exercise improves the young patients' physical fitness and overall health status, and perception of health-related quality of life, respectively.
Collapse
|
91
|
Ezziddin S, Khalaf F, Vanezi M, Haslerud T, Mayer K, Al Zreiqat A, Willinek W, Biersack HJ, Sabet A. Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2014; 41:925-33. [PMID: 24504504 DOI: 10.1007/s00259-013-2677-3] [Citation(s) in RCA: 134] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2013] [Accepted: 12/20/2013] [Indexed: 02/07/2023]
Abstract
PURPOSE The clinical benefit of peptide receptor radionuclide therapy (PRRT) in patients with pancreatic neuroendocrine tumours (pNET) has not yet been well described and defined in its full extent due to limited data in this tumour subgroup. This study was intended to obtain robust, comparative data on the outcome and toxicity of standardized PRRT with (177)Lu-octreotate in a well-characterized population of patients with advanced pNET of grade 1/2 (G1/2). METHODS We retrospectively analysed a cohort of 68 pNET patients with inoperable metastatic disease consecutively treated with (177)Lu-octreotate (four intended cycles at 3-monthly intervals; mean activity per cycle 8.0 GBq). Of these 68 patients, 46 (67.6 %) had documented morphological tumour progression during the 12 months before initiation of treatment, and PRRT was the first-line systemic therapy in 35 patients (51.5 %). Response was evaluated according to modified Southwest Oncology Group (SWOG) criteria and additionally with Response Criteria in Solid Tumors (RECIST) 1.1. Survival was analysed using Kaplan-Meier curves and Cox proportional hazards model for univariate and multivariate analyses. Toxicity was assessed by standard follow-up laboratory work-up including blood count, and liver and renal function, supplemented with serial (99m)Tc-DTPA clearance measurements. RESULTS The median follow-up period was 58 months (range 4 - 112). Reversible haematotoxicity (grade 3 or more) occurred in four patients (5.9 %). No significant nephrotoxicity (grade 3 or more) was observed. Treatment responses (SWOG criteria) consisted of a partial response in 41 patients (60.3 %), a minor response in 8 (11.8 %), stable disease in 9 (13.2 %), and progressive disease in 10 (14.7 %). Median progression-free survival (PFS) and overall survival (OS) were 34 (95 % CI 26 - 42) and 53 months (95 % CI 46 - 60), respectively. A G1 proliferation status was associated with longer PFS (p = 0.04) and OS (p = 0.044) in the multivariate analysis. Variables linked to impaired OS, on the other hand, were a reduced performance status (Karnofsky score ≤ 70 %, p = 0.007), a high hepatic tumour burden (≥ 25 % liver volume, p = 0.017), and an elevated plasma level of neuron-specific enolase (NSE >15 ng/ml, p = 0.035). CONCLUSION The outstanding response rates and survival outcomes suggest that PRRT is highly effective in advanced G1/2 pNET when compared to data of other treatment modalities. Independent predictors of survival are the tumour proliferation index, the patient's performance status, tumour burden and baseline plasma NSE level.
Collapse
|
92
|
Lin DHM, Manara D, Varga Z, Berlizov A, Fanghänel T, Mayer K. Applicability of Raman spectroscopy as a tool in nuclear forensics for
analysis of uranium ore concentrates. ACTA ACUST UNITED AC 2013. [DOI: 10.1524/ract.2013.2110] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Abstract
In the present study, the suitability of Raman spectroscopy for nuclear forensics is proven by a systematic investigation of
laboratory-prepared synthetic and industrial uranium ore concentrate (UOC) samples, of different origin and with wide range of
impurity content. Besides the identification of the compound type, the identification of process-related impurities observed in
these samples is reported for the first time. Both handheld and laboratory Raman spectrometers were used in the
measurements. The ability to measure different UOCs and the sufficient sensitivity of the handheld device demonstrate its
usefulness in nuclear safeguards and nuclear security applications. Even more importantly in such a context, the likely
identity of process-related impurities could be verified by Raman Spectroscopy in the present work, allowing to draw
conclusions on the process history of the sample.
Collapse
|
93
|
Mayer K. COMMUNICATION SUR L'ENSEIGNEMENT THEORIOUE ET PRATIQUE DE LA RADIOLOGIE MEDICALE. Acta Radiol 2013. [DOI: 10.1177/02841851300110s419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
94
|
Mayer K, Gielen GH, Willinek W, Müller MC, Wolf D. Fatal progressive cerebral ischemia in CML under third-line treatment with ponatinib. Leukemia 2013; 28:976-7. [PMID: 24170029 DOI: 10.1038/leu.2013.320] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
95
|
Sabet A, Ezziddin K, Pape UF, Ahmadzadehfar H, Mayer K, Pöppel T, Guhlke S, Biersack HJ, Ezziddin S. Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate. J Nucl Med 2013; 54:1857-61. [DOI: 10.2967/jnumed.112.119347] [Citation(s) in RCA: 106] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
96
|
Ockenga J, Mayer K. PP057-SUN PROINFLAMMATORY PATTERN OF FREE FATTY ACIDS IN CHRONIC PANCREATITIS. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60102-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
97
|
Erika Held S, Heine A, Mayer K, Kapelle M, Friedrich Wolf D, Brossart P. Advances in Immunotherapy of Chronic Myeloid Leukemia CML. Curr Cancer Drug Targets 2013; 13:768-74. [DOI: 10.2174/15680096113139990086] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2012] [Revised: 05/13/2013] [Accepted: 07/03/2013] [Indexed: 11/22/2022]
|
98
|
Orban M, Bernlochner I, Braun S, Hadamitzky M, Mehilli J, Massberg S, Kastrati A, Sibbing D, Mayer K. Obesity and a history of low response to clopidogrel treatment are predictors for a reduced antiplatelet action of prasugrel treatment. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p4909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
99
|
Mayer K, Schulz S, Bernlochner I, Morath T, Braun S, Hausleiter J, Schunkert H, Laugwitz KL, Kastrati A, Sibbing D. The impact of personalized antiplatelet treatment on early adverse events in PCI-treated patients with high on-clopidogrel platelet reactivity: results of the ISAR-HPR registry. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p4872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
100
|
Hecker M, Mayer K. Intensivpatienten: Gabe von Glutamin und Antioxidanzien sinnvoll? Glutamin-Supplementierung nur noch in Sonderfällen. Dtsch Med Wochenschr 2013; 138:1344. [DOI: 10.1055/s-0032-1329051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|